{"schema_version":"secwatch.filing_event.v1","accession":"0001808805-23-000005","form_type":"8-K","ticker":"NAUT","cik":"0001808805","company_name":"Nautilus Biotechnology, Inc.","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.678133+00:00","generated_at":"2026-06-19T03:12:49.514060+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nautilus Biotechnology reports FY2022 net loss of $57.9M; cash runway into 2025","bullets":["Net loss $57.9M for FY2022 vs $50.3M in FY2021; operating expenses $63.6M, up 26%.","Cash, cash equivalents, and investments $313.6M as of Dec 31, 2022; runway into 2025.","Strategic partnership with TGen to study Nautilus platform for DIPG childhood cancer.","Opened San Diego office in University Town Center to expand geographic footprint.","Q4 2022 expenses below peak Q4 2021 levels, helping preserve cash."],"urls":{"canonical":"https://secwatch.observer/filing/0001808805-23-000005","json":"https://secwatch.observer/filing/0001808805-23-000005.json","markdown":"https://secwatch.observer/filing/0001808805-23-000005.md","text":"https://secwatch.observer/filing/0001808805-23-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808805/000180880523000005/0001808805-23-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808805/000180880523000005/naut-20230223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T03:12:49.514060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c43f3401a5b74301f97391875204acf36756711e","claim":"Nautilus Biotechnology, Inc. reported the year-ended December 31, 2022 results: net income $57.9 million.","evidence_excerpt":"Net loss was $57.9 million for the year-ended December 31, 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880523000005/0001808805-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year-ended December 31, 2022"},{"label":"Net income","value":"$57.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}